Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.
In response to the U.S. Preventive Services Task Force’s (USPSTF) recommendation stating that there is insufficient evidence to assess the balance of benefits and harms of calcium and vitamin D supplementation for the primary prevention of fractures, the National Osteoporosis Foundation (NOF) reminds the public that both nutrients are an important part of bone health management.
In response to a study published in the February issue of JAMA Internal Medicine suggesting a link between a high intake of supplemental calcium and heart disease risk among men, the National Osteoporosis Foundation (NOF) reminds individuals to talk with their healthcare providers about the appropriate amount of calcium they need for bone health and fracture prevention.
The National Osteoporosis Foundation has named Barbara Hannah Grufferman as its first Bone Health Ambassador. In this newly-established role, Grufferman, a well-known advocate for healthy and positive living, will dedicate her time, talent and energy to raise awareness for osteoporosis and the importance of building strong bones for life.
Thanks to a generous gift from The Samuel J. & Ethel LeFrak Charitable Trust, the National Osteoporosis Foundation met its Generations of Strength fundraising goal one year early. NOF launched the Generations of Strength initiative in September 2011 with the goal of raising $2 million in two years to improve patient care for the most vulnerable – those who have broken bones due to osteoporosis – and to protect future generations from the disease.
The National Osteoporosis Foundation (NOF), the nation’s leading health organization dedicated to preventing osteoporosis and broken bones, has named Claire Gill as its Senior Director of Marketing, Consumer and Corporate Outreach. Gill brings extensive experience in public relations and marketing communications to this newly-established role.
New NOF-commissioned research published online by Osteoporosis International found that postmenopausal women who complied with taking 1,000 milligrams (mg) of calcium and 400 international units (IU) of vitamin D supplements for five years significantly reduced their risk for hip fracture by 38 percent. The study is also the latest research to be released showing no statistically significant link between calcium supplementation and increased risk of heart disease.
WASHINGTON, DC (October 22, 2012) – The National Osteoporosis Foundation (NOF), the nation’s leading community-focused health organization dedicated to preventing osteoporosis and broken bones, is partnering with WebMD, the leading source of health information, to provide answers to the tens of millions of consumers who turn to WebMD with their health and wellness questions, through the newly launched WebMD Answers.